Vaccination with recombinant vaccinia viruses protects mice against Mycobacterium tuberculosis infection

Immunology

Volumn 92, Issue 1, 1997, Pages 6-9

  Zhu, X ^a   Venkataprasad, N ^a   Ivanyi, J ^a   Vordermeier, H M ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CD8 ANTIGEN; CONCANAVALIN A; DNA VACCINE; GAMMA INTERFERON; GLYCOLIPID; LIPOPROTEIN; PEROXIDASE; RAS PROTEIN; VACCINIA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL COUNT; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INFECTION PREVENTION; INOCULATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TUBERCULOSIS; VACCINATION; VACCINIA VIRUS; VIRUS RECOMBINANT;

EID: 0030820356     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.00358.x     Document Type: Article

References (30)

1. FINE P.E.M. & RODRIGUE L.C. (1991) Modern vaccines: mycobacterial diseases. The Lancet 335, 1016.
2. FLYNN J.L., GOLDSTEIN M.M., TRIEBOLD K.J., KOLLER B. & BLOOM B.R. (1992) Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 89, 12 013.
3. + cells in tuberculosis. Lancet 339, 315.
4. + T cell lines. Eur J Immunol 18, 59.
5. + T cells. Infect Immun 55, 2037.
6. + T cells in vitro. Immunology 87, 339.
7. TASCON R.E., COLSTON M.J., RAGNO S., STAVROPOULOS E., GREGORY D. & LOWRIE D.B. (1996) Vaccination against tuberculosis by DNA injection. Nature Medicine 2, 888.
8. HUYGEN K., CONTENT J., OLIVIER D. et al. (1996) Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nature Medicine 2, 893.
9. ZHU X., VENKATAPRASAD N., THANGARAJ H. et al. (1997) Functions and specificity of T cells following nucleic acid vaccination of mice against M tuberculosis infection. J Immunol 158, 5921.
10. PERALIS M.A., SCHWARTZ D.H., FABRY J.A. & LIEBERMAN J. (1995) A vaccinia-gp160-based vaccine but not a gp160 protein vaccine elicits anti-gp160 cytotoxic T lymphocytes in some HIV-1 seronegative vaccinees. J Acquir Immune Defic Syndr Hum Retrovirol 10, 27.
11. SHIRAI M., AKATSUKA T., PENDLETON C.D. et al. (1992) Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein. J Virol 66, 4098.
12. + T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodies. J Virol 66, 1277.
13. AN L.L., PAMER E. & WHITTON J.L. (1996) A recombinant minigene vaccine containing a nonameric cytotoxic-T-lymphocyte epitope confers limited protection against Listeria monocytogenes infection. Infect Immun 64, 1685.
14. ANDERSEN A.B. & HANSEN E.B. (1989) Structure and mapping of antigenic domains of protein antigen b, a 38 000-molecular-weight protein of Mycobacterium tuberculosis. Infect Immun 57, 2481.
15. ASHBRIDGE K.R., BOOTH R.J., WATSON J.D. & LATHIGRA R.B. (1989) Nucleotide sequence of the 19 kDa antigen gene from Mycobacterium tuberculosis. Nucleic Acids Res 17, 1249.
16. d mice. Scand J Immunol 42, 557.
17. SINGH M., ANDERSEN A.B., MCCARTHY J.E. et al. (1992) The Mycobacterium tuberculosis 38-kDa antigen: overproduction in Escherichia coli, purification and characterization. Gene 117, 53.
18. HARRIS D.P., VORDERMEIER H.M., ROMAN E. et al. (1991) Murine T cell-stimulatory peptides from the 19-kDa antigen of Mycobacterium tuberculosis. Epitope-restricted homology with the 28-kDa protein of Mycobacterium leprae. J Immunol 147, 2706.
19. HARRIS D.P., VORDERMEIER H.M., BRETT S.J., PASVOL, G., MORENO C. & IVANYI J. (1994) Epitope specificity and isoforms of the mycobacterial 19-kilodalton antigen. Infect Immun 62, 2963.
20. YOUNG D., KENT L., REES A., LAMB J. & IVANYI J. (1986) Immunological activity of a 38-kilodalton protein purified from Mycobacterium tuberculosis. Infect Immun 54, 177.
21. ESPITIA C. & MANCILLA R. (1989) Identification, isolation and partial characterization of Mycobacterium tuberculosis glycoprotein antigens. Clin Exp Immunol 77, 378.
22. GARBE T., HARRIS D., VORDERMEIER M., LATHIGRA R., IVANYI J. & YOUNG D. (1993) Expression of the Mycobacterium tuberculosis 19-kilodalton antigen in Mycobacterium smegmatis: immunological analysis and evidence of glycosylation. Infect Immun 61, 260.
23. SKIPPER J. & STAUSS H.J. (1993) Identification of two cytotoxic T lymphocyte-recognised epitopes in the RAS protein. J Exp Med 177, 1493.
24. FENNER F., HENDERSON D.A., ARITA L., JEZEK Z. & LADNYI L.D. (1988) Smallpox and its eradication. World Health Organisation, Geneva.
25. BORVSIEWICZ L.K., FIANDER A., NIMAKO M. et al. (1996) A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer. Lancet 347, 1523.
26. PASTORET P.P. & BROCHIER B. (1996) The development and use of a vaccinia-rabies recombinant oral vaccine for the control of wildlife rabies; a link between Jenner and Pasteur. Epidemiol Infect 116, 235.
27. LYONS J., SINOS C., DESTREE A. et al. (1990) Expression of Mycobacterium tuberculosis and Mycobacterium leprae proteins by vaccinia virus. Infect Immun 58, 4089.
28. BAUMGART K.W., MCKENZIE K.R., RADFORD A.J., RAMSHAW I. & BRITTON W.J. (1996) Immunogenicity and protection studies with recombinant mycobacteria and vaccinia vectors coexpressing the 18-kilodalton protein of Mycobacterium leprae. Infect Immun 64, 2274.
29. VORDERMEIER H.M. (1995) T cell recognition of mycobacterial antigens. Europ Resp J 8 (Suppl. 20), 657s.
30. LATHIGRA R., ZHANG Y., HILL M., GARCIA M.J., JACKETT P.S. & IVANYI J. (1996) Lack of production of the 19 kDa glycolipoprotein in certain strains of Mycobacterium tuberculosis. Res Microbiol 147, 237.